Imagine standing on a vast, dark plain. Without light, you cannot see dips and rolls in the grass or make out hills and ...

While I see generative AI emerging as healthcare’s most transformative disruptor, its full potential relies on robust data ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Pathology is a field that seems ripe for assistance from recent advances in artificial intelligence. Beck’s company is one of ...

Staffing shortages, rising costs, efforts to reduce administrative burden on clinicians and other factors are leading many ...

and helping researchers parse large volumes of literature It has also created a model that could improve AI-powered drug ...

Lexicon's stock rose 60% after securing a potential $1 billion deal with Novo Nordisk for preclinical obesity drug LX9851.

A drug-resistant type of bacteria that has adapted to health care settings evolved in the past several years to weaponize an antimicrobial genetic tool, eliminating its cousins and replacing them as ...

Removing a reliable drug provider can often lead people to ... she’s never been able to find competent intersex-affirming health care. And she fears that the Trump administration’s policies ...